Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) traded down 1% on Friday . The company traded as low as $44.46 and last traded at $44.62. 23,381 shares traded hands during trading, a decline of 31% from the average session volume of 33,707 shares. The stock had previously closed at $45.06.
Wall Street Analyst Weigh In
Separately, BNP Paribas downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
Check Out Our Latest Analysis on Sandoz Group
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- What Are Growth Stocks and Investing in Them
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Oilfield Leader SLB: An AI Name You Need to Know
- Top Biotech Stocks: Exploring Innovation Opportunities
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
